0
Article |

Enders' Live Measles-Virus Vaccine with Human Immune Globulin:  II. Evaluation of Efficacy

MAURICE R. HILLEMAN, Ph.D.; JOSEPH STOKES JR., M.D.; EUGENE B. BUYNAK, Ph.D.; ROBERT WEIBEL, M.D.; RONALD HALENDA, M.D.; HERMAN GOLDNER, Ph.D.
Am J Dis Child. 1962;103(3):372-379. doi:10.1001/archpedi.1962.02080020384038.
Text Size: A A A
Published online

Enders' live attenuated measles-virus vaccine 1 has provided the key to control and possible eventual eradication of this most important disease of childhood. The numerous studies now recorded have shown the uniform effectiveness of the vaccine for inducing neutralizing and CF antibodies in susceptible children, and Krugman et al.2 and Hoekenga et al.3 have demonstrated conclusively that the vaccine given alone affords protection against the natural disease in epidemics. The vaccine virus, even though markedly attenuated, still has the drawback of causing significant clinical reaction, primarily in the nature of rash and fever. These reactions are sufficiently great to preclude general patient and physician acceptance. Consequently, further modification of vaccine reaction is needed.

Early efforts by our group4 to modify the clinical response by administration of vaccine to babies who had maternal antibody were unsuccessful because of apparent total neutralization of the virus. Failing this, vaccination was

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();